| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | EVP, General Counsel | $4.57M | Apr 29, 2025 | ||
| RGNX | REGENXBIO Inc. | Director | $176K | May 30, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|